Main > A2. TRADEMARK. INDEX. N-Nm > Namenda

Product IE. A

GENERIC NAME This data is not available for free
INDICATION'S This data is not available for free
MARKETER'S COUNTRY USA
MECHANISM OF ACTION NMDA AntAgonist
STATUS USA>Approved
- 1/Day ER Form.>(+) Phase III Results
- USA Patent Expiration: 04.11.2010
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back